CHICAGO, May 1 /PRNewswire-FirstCall/ -- The Female Health Company (NYSE Amex: FHC) today announced that it will host an investor conference call to discuss its operating results for the second quarter and first half of FY2009 at 11:00 a.m. Eastern Time (EDT) on Friday, May 8, 2009. The Company expects to report its second quarter and first half FY 2009 operating results earlier the same day.
Shareholders and other interested parties may participate in the conference call by dialing 800-860-2442 (international participants dial 412-858-4600) and asking to be connected to "The Female Health Company Conference Call", a few minutes before 11:00 a.m. EDT on May 8, 2009. A replay of the call will be available one hour after the call through 5:00 p.m. EDT on May 26, 2009 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID 430401.
About The Female Health Company
The Female Health Company (FHC), headquartered in Chicago, IL, is the maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering women dual protection against both sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources Ltd., the holder of exclusive worldwide rights to FC1. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People's Republic of China, South Korea and Japan. FC2 patents have been granted in Australia and South Africa and are pending in various other countries. FHC is the sole manufacturer and marketer of the FC1 and FC2 female condoms in the world. The Fe
|SOURCE The Female Health Company|
Copyright©2009 PR Newswire.
All rights reserved